Enlivex Therapeutics Ltd. (ENLV) Earnings
|
Expand Research on ENLV
| Next EPS Date | 6/22/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +46.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/22/26 |
Q126 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 12/1/25 |
Q325 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/29/25 |
Q225 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/27/25 |
Q225 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/26/25 |
Q225 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/25/25 |
Q225 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/25 |
Q225 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A |


